Uniphos Enterprises Limited (IN:UNIENTER)
:UNIENTER
Want to see IN:UNIENTER full AI Analyst Report?
Top Page
Uniphos Enterprises Limited
(UNIENTER)
Select Model
Select Model
Rating:46Neutral
Price Target:
₹108.00
▼(-25.70% Downside)
Action:ReiteratedDate:03/11/26
The score is held down primarily by weak operating profitability and persistently negative operating/free cash flow, despite strong recent revenue growth. A debt-free, equity-heavy balance sheet provides stability, but technicals remain bearish (below major moving averages with negative MACD) and valuation signals are not supportive given a negative P/E and low dividend yield.
Positive Factors
Balance Sheet Strength
Zero debt and a sizable equity base materially reduce financial risk and give management durable flexibility to support investee companies, make opportunistic investments, or absorb operating volatility. Over a 2-6 month horizon this positions the company to act without needing external financing.
Negative Factors
Negative Cash Flow
Recurring negative operating and free cash flow demonstrates the business is not self-funding operations. Persistent cash deficits erode liquidity, force reliance on asset sales or capital injections, and constrain reinvestment, dividends, or strategic initiatives over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Zero debt and a sizable equity base materially reduce financial risk and give management durable flexibility to support investee companies, make opportunistic investments, or absorb operating volatility. Over a 2-6 month horizon this positions the company to act without needing external financing.
Read all positive factors
Uniphos Enterprises Limited (UNIENTER) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.74B
Dividend Yield0.34%
Average Volume (3M)1.50K
Price to Earnings (P/E)―
Beta (1Y)1.06
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees2,022
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.14
Shares Outstanding69,545,845
10 Day Avg. Volume885
30 Day Avg. Volume1,505
Financial Highlights & Ratios
PEG Ratio-38.21
Price to Book (P/B)0.39
Price to Sales (P/S)9.47
P/FCF Ratio-388.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Uniphos Enterprises Limited Business Overview & Revenue Model
Company Description
Uniphos Enterprises Limited engages in trading of chemicals and other products in India. The company also invests in quoted and unquoted securities. Uniphos Enterprises Limited was incorporated in 1969 and is based in Mumbai, India. Uniphos Enterp...
How the Company Makes Money
Uniphos Enterprises Limited primarily makes money through income generated from its investment and holding activities. Key revenue/earnings sources typically include: (1) dividends and other distributions received from investee companies or group ...
Uniphos Enterprises Limited Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
78
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 838.64M | 1.12B | 506.48M | 14.72M | 12.22M | 8.33M |
| Gross Profit | 3.63M | 8.02M | 652.00K | 164.00K | -11.00K | 75.00K |
| EBITDA | 208.31M | 22.99M | -30.90M | -28.63M | -31.26M | -30.64M |
| Net Income | 189.89M | 2.78M | 386.14M | 392.25M | 546.04M | 244.51M |
Balance Sheet | ||||||
| Total Assets | 29.62B | 28.42B | 20.78B | 30.95B | 33.02B | 27.72B |
| Cash, Cash Equivalents and Short-Term Investments | 223.74M | 162.37M | 469.95M | 517.30M | 391.46M | 451.52M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.18B | 1.00B | 20.50M | 978.68M | 1.21B | 569.04M |
| Stockholders Equity | 28.44B | 27.42B | 20.75B | 29.98B | 31.81B | 27.15B |
Cash Flow | ||||||
| Free Cash Flow | -20.75M | -27.17M | -34.67M | -14.66M | 5.20M | -45.87M |
| Operating Cash Flow | -20.75M | -27.17M | -34.67M | -14.66M | 5.20M | -45.87M |
| Investing Cash Flow | 65.05M | 527.70M | 501.62M | 406.29M | 204.34M | -338.62M |
| Financing Cash Flow | -34.77M | -409.58M | -452.05M | -392.93M | -236.46M | 0.00 |
Uniphos Enterprises Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹12.69B | 17.66 | ― | 0.52% | 28.67% | 50.12% | |
71 Outperform | ₹7.93B | 10.26 | ― | 0.81% | -4.92% | 1.29% | |
64 Neutral | ₹8.02B | 19.71 | ― | 0.38% | 13.01% | 32.44% | |
63 Neutral | ₹8.24B | 9.34 | ― | 0.56% | -7.93% | 11.44% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ₹5.67B | -33.35 | ― | 0.28% | 5.19% | -152.09% | |
46 Neutral | ₹7.74B | -247.22 | ― | 0.34% | ― | ― |
* Basic Materials Sector Average
IN:UNIENTER
Uniphos Enterprises Limited
111.30
-45.88
-29.19%
IN:CHEMFAB
Chemfab Alkalis Ltd.
394.80
-410.71
-50.99%
IN:INDOAMIN
Indo Amines Limited
110.47
-21.27
-16.15%
IN:KOTHARIPET
Kothari Petrochemicals Ltd.
134.73
-24.83
-15.56%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
392.40
149.74
61.71%
IN:SRHHYPOLTD
Sree Rayalaseema Hi-Strength Hypo Limited
480.10
-52.61
-9.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.